Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
11.85
+0.21 (1.80%)
At close: May 12, 2025, 4:00 PM
11.85
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Ostoarthritis Pain Management | 101.93M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ostoarthritis Pain Management Growth | 4.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Joint Preservation and Restoration | 54.88M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Joint Preservation and Restoration Growth | 8.88% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Non-Orthopedic | 9.86M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Non-Orthopedic Growth | 24.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthobiologics | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthobiologics Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Surgical | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Surgical Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Dermal | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Dermal Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Licensing, Milestone and Contract | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Licensing, Milestone and Contract Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| United States | 123.13M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 3.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 21.72M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 5.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 21.81M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 32.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|